Caresyntax recognized by Goldman Sachs and Business Insider31 Aug 2018
Originally published on August 29, 2018, caresyntax was featured on Business Insider’s list of The 10 Biggest Start-Ups to raise funding in Q2 of 2018!
“Next-generation environmental monitoring. Neural interface technology. Space catapults.
These are some of the far-out visions being pursued by a promising bunch of startups that might just be the business titans of tomorrow.
In a recent research note circulated to clients, Goldman Sachs highlighted the ten “software and internet” startups that had raised the most Series A investment in the second quarter of 2018, based on data collected by venture capital monitoring firm CB Insights.
Series A funding is some of the very first investment companies will receive in their life-cycle — right after seed or angel funding — indicating that it’s still early days for these firms. But these young firms still collectively raised more than $400 million in the last three months, in industries ranging from healthcare to real estate to aeronautics.
There’s no telling yet whether they will all be able to achieve their heady dreams — but together they offer a glimpse at what the world’s top investors are betting will be the technologies and products that will transform our world in the years to come.
Caresyntax ($20 million) is providing clinicians with more data.
Caresyntax is focused in the medical space, and provides clinicians with data analytics to “identify deviations from benchmarks in processes and outcomes, “address workflow efficiency bottlenecks,” and more.
It was founded in 2013 in Germany by Dennis Kogan and Björn von Siemens before expanding to the US in 2017. In June 2018 it got a $20 million cash injection from healthcare AI investment fund Surgical.AI.”